YSB’s B2B Pharma Platform: Sexier Than the SOEs, But Stodgier Than B2Cs
The drug distributor for pharmacies and community-level medical institutions has filed for a Hong Kong listing, boasting strong revenue growth but also massive losses Key Takeaways: YSB has filed for…
